Published online before print September 28, 2006, doi: 10.1161/01.STR.0000245134.12145.ae
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:2802.)
© 2006 American Heart Association, Inc.
Original Contributions |
Modulation of Dilator Responses of Cerebral Arterioles by Extracellular Superoxide Dismutase
From the Cardiovascular Center and Departments of Internal Medicine and Pharmacology, University of Iowa Carver College of Medicine and VA Medical Center, Iowa City, Iowa.
Correspondence to Donald D. Heistad, MD, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242-1081. E-mail donald-heistad{at}uiowa.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background and Purpose— Extracellular superoxide dismutase (ECSOD) is highly expressed in the wall of blood vessels and plays an important role in modulation of vascular function in extracranial arteries. Expression of ECSOD appears to affect cerebral vascular responses during disease states. Effects of ECSOD on dilator function in cerebral arterioles, however, have not been fully elucidated. In the present study, we examined effects of ECSOD deficiency on cerebrovascular reactivity under control conditions and during oxidative stress.
Methods— Dilator responses of cerebral arterioles were examined in cranial windows in vivo in anesthetized ECSOD-deficient (–/–) and wild-type (+/+) mice under normal conditions and during oxidative stress induced by angiotensin II.
Results— Total SOD activity in the aorta in ECSOD–/– mice (176±24 [mean±SEM] U/mg) was approximately 30% lower than in ECSOD+/+ mice (270±38, P=0.051). Dilator responses to acetylcholine (10 µmol/L) in cerebral arterioles were similar under control conditions in ECSOD+/+ (34±5% changes in diameter) and –/– mice (32±4%). Angiotensin II (500 nmol/L for 30 minutes) tended to reduce responses to acetylcholine in ECSOD+/+ mice (not significant) and significantly impaired responses in ECSOD–/– mice (42% reduction, P<0.05). Tempol (1 mmol/L), a scavenger of superoxide, restored the impaired dilator responses in ECSOD–/– mice. Responses to nitroprusside in cerebral arterioles were similar in ECSOD+/+ and –/– mice and were not affected by angiotensin II nor by tempol.
Conclusions— ECSOD deficiency has little effect on cerebrovascular reactivity in control conditions but plays an important role in the regulation of vascular tone during oxidative stress produced by angiotensin II.
Key Words: angiotensin II • cerebral circulation • endothelium • nitric oxide • oxidative stress
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Under physiological conditions, small amounts of reactive oxygen species are generated in the wall of blood vessels and are important in signaling and regulation of vascular tone.1–3 Overproduction of reactive oxygen species, mainly superoxide, is associated with several cardiovascular risk factors, including hypertension,4 hyperlipidemia,5 diabetes,6 cigarette smoking,7 and aging8 and may play an important role in vascular dysfunction. Superoxide reacts with nitric oxide (NO) released from endothelial cells limits bioavailability of NO and thus impairs endothelium-dependent dilator responses.
To protect against oxidative damage, there are several endogenous antioxidant mechanisms, including a group of superoxide dismutase (SODs).9 Extracellular SOD (ECSOD) is the only isoform of SOD that is distributed in the extracellular matrix and plasma.9,10 ECSOD is highly expressed in blood vessels, particularly in the arterial wall, and its activity constitutes almost half of the total SOD activity in aorta of humans.11,12 Thus, expression and activity of ECSOD in the arterial wall may be important in protection of vascular function during oxidative stress.
A study13 in transgenic mice with overexpression of ECSOD reported that baseline regional cerebral blood flow and responses to acetylcholine were significantly greater than in ECSOD-deficient mice, but responses to acetylcholine were similar in ECSOD-deficient mice and in wild-type mice. Thus, under baseline conditions, endogenous ECSOD does not appear to regulate basal regional cerebral blood flow or vasodilator responses. Vasomotor responses were not examined during oxidative stress.
In this study, we tested the hypothesis that ECSOD may modulate endothelium-dependent dilator responses of cerebral arterioles during oxidative stress. We examined effects of angiotensin II, which generates oxidative stress,14,15 on dilator responses of cerebral arterioles in vivo in wild-type and ECSOD-deficient mice. Responses also were examined in the presence of tempol,16 a scavenger of superoxide.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Experimental Animals
Breeding pairs of ECSOD-deficient (ECSOD–/–) and wild-type (ECSOD+/+) mice were kindly provided by Dr Ralf Brandes. The mice were originally obtained from Dr Stefan Marklund, who inbred the mice for more than 10 generations. Male F2 ECSOD–/– mice, derived from breeding pairs of heterozygous F1 ECSOD-deficient mice, were used for this study. Animals were studied at 4 to 7 months of age. Sex- and age-matched littermate ECSOD+/+ mice were used as controls. Genotype was determined by polymerase chain reaction (PCR) analysis of DNA extracted from tail snips. Two primers (5'-CCA CGA AGT TGC CAA AGT C-3' and 5'-GCG ACA CGC ATG CCA AAG-3') were used for PCR. After a hot start at 94°C for 3 minutes, PCR was performed for 35 cycles at 94°C for 45 seconds, 59°C for 45 seconds, and 72°C for 4 minutes. Bands for wild-type and mutant ECSOD genes ran at approximately 300 bp and approximately 1.5 kbp, respectively. All procedures followed institutional guidelines approved by the Animal Care and Use Committee at the University of Iowa.
Cranial Window
Mice were anesthetized with pentobarbital sodium (75 to 90 mg/kg intraperitoneal). A catheter in the femoral artery was used to measure arterial pressure and to obtain blood. Mice were ventilated mechanically with supplemental oxygen. Depth of anesthesia was evaluated by applying pressure to a paw or tail and by observing changes in heart rate and blood pressure. Additional anesthetic (approximately 20 mg/kg per hour) was administered when such changes occurred. Arterial blood gases were maintained within normal limits throughout each experiment (pH=7.35±0.01 [mean±SEM], PCO2=39±1 mm Hg, and PO2=119±4 mm Hg). Body temperature was maintained at approximately 37°C with a heating pad.
A cranial window was made over the left parietal cortex, and a segment of pial arteriole (27±1 µm diameter) was exposed. After part of the dura was opened, the cranial window was suffused with artificial cerebrospinal fluid (temperature 37°C; ionic composition [in mmol/L]: 132 NaCl, 2.95 KCl, 1.71 CaCl2, 0.65 MgCl2, 24.6 NaHCO3, 3.69 D-glucose) that was bubbled continuously with 5% CO2 and 95% N2 to maintain normal levels of pH and PCO2. The window was suffused with artificial cerebrospinal fluid at approximately 3 mL/minute beginning at least 30 minutes before measurement. In cerebrospinal fluid sampled from the cranial window, pH was 7.39±0.02, PCO2 was 36±1 mm Hg, and PO2 was 131±2 mm Hg.
Diameter of cerebral arterioles was recorded and measured using a microscope, video recorder, and a dimension analyzer. The diameter of one arteriole per animal was measured under control conditions and during topical application of acetylcholine (1 and 10 µmol/L) and sodium nitroprusside (0.01 and 0.1 µmol/L).17 The vasodilators were suffused over the craniotomy for 5 minutes, and internal diameter of the pial arteriole was measured. Topical application of these agents did not produce any changes in systemic arterial pressure or prolonged change in arteriolar diameter after suffusion of a drug was stopped. Vasodilator responses to acetylcholine and nitroprusside were examined before and during superfusion of angiotensin II (500 nmol/L) with or without tempol (1 mmol/L), a superoxide scavenger, for 30 minutes. All other drugs were dissolved and diluted in normal saline. Concentrations are expressed as final concentration of each drug in the cranial window.
Superoxide Dismutase Assay
Total SOD activity of aortic homogenates from ECSOD+/+ and ECSOD–/– mice was determined as previously described.17–19 Measurement of enzyme activity is based on competition of SOD and nitroblue-tetrazolium (NBT) for superoxide; thus, the percent inhibition of NBT reduction is a measure of the amount of SOD present. The rate of NBT reduction to formazan, the photoabsorbant product, was measured spectrophotometrically for 5 minutes at 560 nm. One unit of SOD activity is defined as the amount of protein that results in 50% inhibition of NBT reduction. SOD activity is expressed as units per milligram of protein. Total protein content was determined using a Bio-Rad protein assay kit.
Statistical Analysis
All values are expressed as mean±SEM. Dilatation of pial arterioles to acetylcholine and sodium nitroprusside is expressed as percent change from baseline diameter. Single comparisons were made with unpaired t test, and multiple comparisons were made with repeated measures one-way ANOVA. P<0.05 was considered to be statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Extracellular Superoxide Dismutase in Tissue
In the aorta, total SOD activity was 270±38 U/mg in ECSOD+/+ mice (n=7) and 176±24 U/mg in ECSOD–/– mice (n=8), respectively (P=0.051 versus ECSOD+/+ mice).
Dilator Responses of Cerebral Arterioles
Baseline diameter of cerebral arterioles was similar in both groups of mice and averaged 27±1 µm. In control conditions, dilator responses of cerebral arterioles to acetylcholine and nitroprusside in ECSOD–/– mice were similar to those of ECSOD+/+ mice (Figure 1).
|
Superfusion of the cranial window with 500 nmol/L of angiotensin II for 30 minutes did not alter diameter of cerebral arterioles significantly (not shown). Topical application of angiotensin II did not also change systemic blood pressure. In the presence of angiotensin II, dilator responses to acetylcholine (10–5 mol/L) tended to be reduced in ECSOD+/+ mice compared with controls (34±5 and 28±6%, NS, Figure 1A). In ECSOD–/– mice, responses to acetylcholine (10–5 mol/L) were significantly reduced by angiotensin II (32±4 and 18±4%, P<0.05 versus control, Figure 1C). Nitroprusside-induced dilator responses of cerebral arterioles in ECSOD+/+ and ECSOD–/– mice were not affected by angiotensin II with or without tempol (Figures 1B, 1D and 2B and 2
D).
|
Application of 1 mmol/L of tempol alone did not affect baseline diameter or dilatation of cerebral arterioles to acetylcholine in control mice (data not shown). In the presence of tempol, dilator responses to acetylcholine were not altered by angiotensin II in ECSOD+/+ mice (Figure 2A). Impaired dilator responses to acetylcholine in ECSOD–/– mice in the presence of angiotensin II were restored to normal by tempol (Figure 2C).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The major new findings in this study are that in cerebral arterioles in vivo, deficiency of ECSOD does not affect acetylcholine-induced, NO-mediated dilator responses under control conditions, but endogenous ECSOD appears to play an important role in modulation of dilator responses during oxidative stress produced by angiotensin II.
Superoxide Dismutases in Vasculature
SODs dismute superoxide and play an important role in protecting normal vascular function against oxidative stress.20 There are 3 different isoforms of SODs with different localization: cytosolic copper zinc SOD (CuZnSOD), mitochondrial manganese SOD (MnSOD), and ECSOD. These isoforms are encoded by separate genes, and deficiency or reduction of each SOD isoform has been implicated in vascular dysfunction using genetically altered mice.17,21,22
In aorta from CuZnSOD-deficient mice, total SOD activity is reduced by approximately 60% and superoxide levels are 2-fold greater compared with levels in wild-type mice.17 Maximal relaxation of the carotid artery to acetylcholine is reduced by approximately 30% in CuZnSOD-deficient mice compared with that in wild-type mice.17 MnSOD comprises only 10% or less of total SOD activity in the mouse aorta.12 Although MnSOD is the only isoform that is essential for life and its deficiency induces death soon after birth,23 vascular function and superoxide levels in the aorta appear to be normal in mice heterozygous for MnSOD (MnSOD+/–) under control conditions.21 In addition, acute oxidative stress, induced by hypoxia, does not affect endothelial function in the aorta from MnSOD+/– mice.
Extracellular Superoxide Dismutase ECSOD and Vascular Function
ECSOD is a major SOD isoform in the arterial wall,12,24,25 and it is the only SOD in extracellular space. It has been suggested that ECSOD is the major determinant of NO bioavailability in blood vessels.26 Like other isoforms of SODs, ECSOD appears to play an important role in modulation of reactivity of systemic blood vessels.22
A previous study using ECSOD-deficient mice22 indicated that arterial blood pressure is similar under control conditions in ECSOD-deficient and wild-type mice, although basal superoxide levels in the aorta are higher in ECSOD-deficient mice than in wild-type mice. Clipping of a renal artery, which produces hypertension and increases superoxide levels in blood vessels, induces greater endothelial dysfunction and elevation of arterial pressure in ECSOD-deficient mice. Our present data are consistent with previous results22 that blood pressure under control conditions is similar in ECSOD+/+ and –/– mice.
In a previous study,22 absence of ECSOD activity was associated with normal to very mildly impaired endothelium-dependent dilator responses in the aorta under control conditions. We demonstrated here that vasodilator responses of cerebral arterioles were normal during control conditions in ECSOD–/– mice. We speculate that increased antioxidant mechanisms such as other SODs may compensate under normal conditions for loss of ECSOD activity in cerebral arterioles.
Extracellular Superoxide Dismutase and Cerebral Blood Vessels
Total SOD activity in the aorta observed here was approximately 30% lower in ECSOD–/– mice than in ECSOD+/+ mice. This result is compatible with previous reports.12,27 The reduction of total SOD activity induced by selective loss of ECSOD is not as great as that in CuZnSOD-deficient mice (approximately 60% of reduction) in which acetylcholine-induced dilator responses in cerebral arterioles were reduced by approximately 50% compared with responses in wild-type mice in control conditions.17 It is possible that the reduction in total SOD activity in ECSOD–/– mice is not sufficient to affect endothelial function in small arterioles. It is of interest that endothelial function is not impaired in ECSOD-deficient mice under normal conditions in small pulmonary arteries28 or, using a hydrogen electrode to measure responses, in the cerebral microcirculation.13
We found, however, that endothelium-dependent dilator responses of cerebral arterioles are significantly impaired in ECSOD–/– mice during increased oxidative stress produced by angiotensin II. Angiotensin II generates superoxide through activation of NADPH oxidase in the vascular wall.15,29,30 A recent report indicated that systemic administration of angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through AT1 receptor-mediated, Nox2 (gp91phox)-mediated oxidative stress.15 In mouse pial arterioles, AT1 receptors and Nox2 are present in endothelium and adventitia but not in smooth muscle cells.31 Superoxide from activation of NADPH oxidase reacts with NO immediately after generation within the endothelial cell, ie, an intracellular reaction. In vessels from ECSOD–/– mice, superoxide levels are higher than in wild-type mice during renovascular hypertension,22 suggesting that a substantial amount of superoxide may be dismuted by ECSOD (ie, extracellularly) under conditions with oxidative stress.
In our study, topical application of angiotensin II to the cranial window did not affect systemic arterial pressure, but nevertheless attenuated endothelium-dependent dilator responses of cerebral arterioles in ECSOD–/– mice. A previous study demonstrated31 that superfusion of the cerebral cortex with 100 nmol/L of angiotensin II for 1 hour increased superoxide by approximately 50% in cerebral microvessels in vivo. It is likely that similar or greater levels of superoxide were produced in cerebral arterioles in the present study during superfusion of high doses of angiotensin II. Superoxide inactivates endothelium-derived NO, contributing to impairment of endothelial function. Impairment of dilator responses to acetylcholine in ECSOD–/– mice were restored by tempol, a superoxide scavenger, which supports the conclusion that deficiency of ECSOD augments oxidative stress during angiotensin II.
Like many previous articles that studied endothelial functions of vessels in vivo and in vitro,15,32 we did not find impairment of SNP-induced vasodilatation by oxidative stress even when responses to acetylcholine were impaired. The explanation is not entirely clear, but SNP apparently generates NO within smooth muscle and thus may be relatively inaccessible to extracellular oxidative stress. Thus, bioavailability of NO may be relatively preserved during application of nitroprusside.
Several cerebrovascular diseases are associated with oxidative stress. In pathologic conditions, vasodilator responses of cerebral arterioles are impaired by several mechanisms associated with oxidative stress. SODs play an important role in protection against oxidative stress.9,20 ECSOD activity has been reported to affect outcome of cerebrovascular diseases. ECSOD deficiency worsens the outcome after focal cerebral ischemia in mice.33 In contrast, transgenic mice overexpressing ECSOD have increased resistance to focal and global cerebral ischemia.34,35 After subarachnoid hemorrhage, overexpression of ECSOD by gene transfer reduces the risk of vasospasm in rabbits36 but not in dogs.37 This study is the first to demonstrate that ECSOD deficiency modulates cerebrovascular function during oxidative stress. Thus, we conclude that ECSOD may play an important role in cerebral vasculature in protection against oxidative stress.
In contrast to our findings, that dilator responses of cerebral arterioles are normal in ECSOD-deficient mice under control conditions, responses of aorta to acetylcholine are impaired in ECSOD-deficient mice.22 It is possible that in ECSOD–/– mice, other antioxidant mechanisms may upregulate so that responses of cerebral arterioles are normal under control conditions. We measured total SOD activity in aorta, and it was reduced approximately 35% in ECSOD–/– mice compared with ECSOD+/+ mice. It would be very difficult to measure ECSOD activity in cerebral arterioles of mice.
Summary
We conclude that ECSOD deficiency may not affect cerebrovascular reactivity under control conditions but plays an important role in regulation of vascular tone under conditions with increased oxidative stress. Angiotensin II induces oxidative stress by activation of NADPH oxidase in wild-type mice, and we speculate that a similar mechanism may generate oxidative stress in ECSOD-deficient mice. We did not, however, measure activity of NADPH oxidase or the levels of superoxide radical in cerebral arterioles in ECSOD-deficient mice. Thus, this hypothesis has not yet been tested directly.
|
Acknowledgments |
|---|
The authors thank Arlinda LaRose for secretarial assistance.
Sources of Funding
This work was supported by National Institutes of Health grants NS24621, HL62984, HL16066, HL38901, HL55006, and HL14388; funds from the VA Medical Service; the American Heart Association (0575092N); and a Carver Trust Research Program of Excellence.
Disclosures
None.
Received July 21, 2006; accepted August 8, 2006.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Miller AA, Drummond GR, Schmidt HHHW, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005; 97: 1055–1062.
2. Didion SP, Faraci FM. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002; 282: H688–H695.
3. Paravicini TM, Chrissobolis S, Drummond GR, Sobey CG. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke. 2004; 35: 584–589.
4. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension. 2004; 44: 248–252.
5. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993; 91: 2546–2551.[Medline] [Order article via Infotrieve]
6. Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes. 2004; 53 (suppl 1): S110–S118.
7. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol. 2002; 33: H575–H586.
8. Sohal RS, Mockett RJ, Orr WC. Mechanisms of aging; an appraisal of the oxidative stress hypothesis. Free Radic Biol Med. 2002; 33: 575–586.[CrossRef][Medline] [Order article via Infotrieve]
9. Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med. 2003; 35: 236–256.[CrossRef][Medline] [Order article via Infotrieve]
10. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase; a regulator of nitric oxide bioavailability. Lab Invest. 1996; 75: 617–636.[Medline] [Order article via Infotrieve]
11. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med. 1996; 20: 957–965.[CrossRef][Medline] [Order article via Infotrieve]
12. Strålin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995; 15: 2032–2036.
13. Demchenko IT, Oury TD, Crapo JD, Piantadosi CA. Regulation of the brain’s vascular responses to oxygen. Circ Res. 2002; 91: 1031–1037.
14. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor function. J Clin Invest. 1996; 97: 1916–1923.[Medline] [Order article via Infotrieve]
15. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arterioscler Thromb Vasc Biol. 2006; 26: 826–832.
16. Krishna MC, Grahame DA, Samuni A, Mitchell JB, Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A. 1992; 89: 5537–5541.
17. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002; 91: 938–944.
18. Nakane H, Chu Y, Faraci FM, Oberley LW, Heistad DD. Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebral spinal fluid. Stroke. 2001; 32: 184–189.
19. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem. 1989; 179: 8–18.[CrossRef][Medline] [Order article via Infotrieve]
20. Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004; 24: 1367–1373.
21. Andresen JJ, Faraci FM, Heistad DD. Vasomotor responses in MnSOD-deficient mice. Am J Physiol Heart Circ Physiol. 2003; 287: H1141–H1148.
22. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res. 2003; 93: 622–629.
23. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Nobel LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995; 11: 376–381.[CrossRef][Medline] [Order article via Infotrieve]
24. Karlsson K, Sandstrom J, Edlund A, Edlund T, Marklund SL. Pharmacokinetics of extracellular-superoxide dismutase in the vascular system. Free Radic Biol Med. 1993; 14: 185–190.[CrossRef][Medline] [Order article via Infotrieve]
25. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J. 1984; 222: 649–655.[Medline] [Order article via Infotrieve]
26. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res. 2002; 55: 239–249.
27. Fukai T, Galis ZS, Meng XP, Parthasarathy S, Harrison DG. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest. 1998; 101: 2101–2111.[Medline] [Order article via Infotrieve]
28. Liu JQ, Folz RJ. Extracellular superoxide enhances 5-HT induced murine pulmonary artery vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L111–L118.
29. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994; 74: 1141–1148.
30. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular disease. Trends Pharmacol Sci. 2003; 24: 471–478.[CrossRef][Medline] [Order article via Infotrieve]
31. Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res. 2004; 95: 1019–1026.
32. Didion SP, Kinzenbaw DA, Faraci FM. Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction. Hypertension. 2005; 46: 1147–1153.
33. Sheng H, Brady TC, Pearlstein RD, Crapo JD, Warner DS. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci Lett. 1999; 267: 13–16.[CrossRef][Medline] [Order article via Infotrieve]
34. Sheng H, Bart RD, Oury TD, Pearlstein RD, Crapo JD, Warner DS. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience. 1999; 88: 185–191.[CrossRef][Medline] [Order article via Infotrieve]
35. Sheng H, Kudo M, Mackensen GB, Pearlson RD, Crapo JD, Warner DS. Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. Exp Neurol. 2000; 163: 392–398.[CrossRef][Medline] [Order article via Infotrieve]
36. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003; 34: 434–440.
37. Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke. 2004; 35: 2512–2517.
This article has been cited by other articles:
 |
|
 |
|
  C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||